Chewy, Inc. (CHWY) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-08-02..
- Stock-based compensation / revenue · 12 months: Value 2.28%; Formula and calculation Share-based compensation / revenue. Period ending 2026-08-02..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-08-02; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-08-02. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.28% | Share-based compensation / revenue. Period ending 2026-08-02. $297.90M ÷ $13.07B × 100 ≈ 2.28% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 13.07B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 297.90M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 328.20M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-02 | (m) | $13.07B | $297.90M | $328.20M | (m) | (m) | 2.28% | (m) | (m) |
| 2026-05-03 | (m) | $12.84B | $290.30M | $305.90M | (m) | (m) | 2.26% | (m) | (m) |
| 2026-02-01 | (m) | $12.60B | $297.90M | $254.30M | (m) | (m) | 2.36% | (m) | (m) |
| 2025-11-02 | (m) | $12.58B | $307.63M | $202.09M | (m) | (m) | 2.44% | (m) | (m) |
| 2025-08-03 | (m) | $12.35B | $309.83M | $162.49M | (m) | (m) | 2.51% | (m) | (m) |
| 2025-05-04 | (m) | $12.10B | $315.54M | $124.89M | (m) | (m) | 2.61% | (m) | (m) |
| 2025-02-02 | (m) | $11.86B | $306.44M | $112.59M | $5.52M | (m) | 2.58% | 20.40× | Reported |
| 2024-10-27 | (m) | $11.44B | $284.92M | $100.32M | $5.14M | (m) | 2.49% | 19.51× | Reported |
| 2024-07-28 | (m) | $11.31B | $271.52M | $64.97M | $4.67M | (m) | 2.40% | 13.92× | Reported |
| 2024-04-28 | (m) | $11.23B | $255.94M | $16.26M | $4.05M | (m) | 2.28% | 4.01× | Reported |
| 2024-01-28 | (m) | $11.15B | $239.11M | $-23.63M | $3.58M | (m) | 2.14% | -6.60× | Reported |
| 2023-10-29 | (m) | $11.01B | $227.32M | $11.70M | $3.31M | (m) | 2.06% | 3.54× | Reported |
| 2023-07-30 | (m) | $10.80B | $208.50M | $21.42M | $3.08M | (m) | 1.93% | 6.97× | Reported |
| 2023-04-30 | (m) | $10.46B | $180.88M | $60.99M | $2.84M | (m) | 1.73% | 21.51× | Reported |
| 2023-01-29 | (m) | $10.10B | $158.12M | $55.75M | $2.57M | (m) | 1.57% | 21.66× | Reported |
| 2022-10-30 | (m) | $9.78B | $123.78M | $-23.15M | (m) | (m) | 1.27% | (m) | (m) |
| 2022-07-31 | (m) | $9.46B | $97.06M | $-54.64M | (m) | (m) | 1.03% | (m) | (m) |
| 2022-05-01 | (m) | $9.18B | $80.46M | $-92.48M | (m) | (m) | 0.88% | (m) | (m) |
| 2022-01-30 | (m) | $8.89B | $77.77M | $-72.18M | (m) | (m) | 0.87% | (m) | (m) |
| 2021-10-31 | (m) | $8.55B | $84.77M | $12.61M | (m) | (m) | 0.99% | (m) | (m) |
| 2021-08-01 | (m) | $8.12B | $90.77M | $12.23M | (m) | (m) | 1.12% | (m) | (m) |
| 2021-05-02 | (m) | $7.66B | $102.14M | $-3.86M | (m) | (m) | 1.33% | (m) | (m) |
| 2021-01-31 | (m) | $7.15B | $121.27M | $-90.46M | (m) | (m) | 1.70% | (m) | (m) |
| 2020-11-01 | (m) | $6.46B | $144.75M | $-172.66M | (m) | (m) | 2.24% | (m) | (m) |
| 2020-08-02 | (m) | $5.91B | $159.29M | $-219.13M | (m) | (m) | 2.70% | (m) | (m) |
| 2020-05-03 | (m) | $5.36B | $169.93M | $-269.94M | (m) | (m) | 3.17% | (m) | (m) |
| 2020-02-02 | (m) | $4.85B | $134.93M | $-252.73M | (m) | (m) | 2.78% | (m) | (m) |
| 2019-11-03 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-08-04 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-05-05 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-02-03 | (m) | $3.53B | $14.35M | $-267.77M | (m) | (m) | 0.41% | (m) | (m) |
| 2018-10-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-07-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-04-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-01-28 | (m) | $2.10B | $11.21M | $-337.85M | (m) | (m) | 0.53% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.